Knowledge Domains and Areas % of CSPT Exam Content
1.0 |
Pharmacology for Technicians |
13.75% |
1.1 |
Generic and brand names of pharmaceuticals |
|
1.2 |
Therapeutic equivalence |
|
1.3 |
Drug interactions (e.g., drug-disease, drug-drug, drug-dietary supplement, drug-OTC, drug-laboratory, drug-nutrient) |
|
1.4* |
Strengths/dose, dosage forms, physical appearance, routes of administration, and duration of drug therapy |
|
1.5 |
Common and severe side or adverse effects, allergies, and therapeutic contraindications associated with medications |
|
1.6 |
Dosage and indication of legend, OTC medications, herbal and dietary supplements |
|
2.0 |
Pharmacy Law and Regulations |
12.50% |
2.1 |
Storage, handling, and disposal of hazardous substances and wastes (e.g., MSDS) |
|
2.2 |
Hazardous substances exposure, prevention and trea®ent (e.g., eyewash, spill kit, MSDS) |
|
2.3 |
Controlled substance transfer regulations (DEA) |
|
2.4 |
Controlled substance documentation requirements for receiving, ordering, returning, loss/theft, destruction (DEA) |
|
2.5 |
Formula to verify the validity of a prescriber’s DEA number (DEA) |
|
2.6 |
Record keeping, documentation, and record retention (e.g., length of time prescriptions are maintained on file) |
|
2.7 |
Restricted drug programs and related prescription-processing requirements (e.g., thalidomide, isotretinoin, clozapine |
|
2.8 |
Professional standards related to data integrity, security, and confidentiality (e.g., HIPAA, backing up and archiving) |
|
2.9 |
Requirement for consultation (e.g., OBRA'90) |
|
2.10 |
FDA’s recall classification |
|
2.11 |
Infection control standards (e.g., laminar air flow, clean room, hand washing, cleaning counting trays, countertop, and equipment) (OSHA, USP 795 and 797) |
|
2.12 |
Record keeping for repackaged and recalled products and supplies (TJC, BOP) |
|
2.13 |
Professional standards regarding the roles and responsibilities of pharmacists, pharmacy technicians, and other pharmacy employees (TJC, BOP) |
|
2.14 |
Reconciliation between state and federal laws and regulations |
|
2.15 |
Facility, equipment, and supply requirements (e.g., space requirements, prescription file storage, cleanliness, reference materials) (TJC, USP, BOP) |
|
3.0 |
Sterile and Non-Sterile Compounding |
8.75% |
3.1 |
Infection control (e.g., hand washing, PPE) |
|
3.2 |
Handling and disposal requirements (e.g., receptacles, waste streams) |
|
3.3* |
Documentation (e.g., batch preparation, compounding record) |
|
3.4* |
Determine product stability (e.g., beyond use dating, signs of incompatibility) |
|
3.5 |
Selection and use of equipment and supplies |
3.6* |
Sterile compounding processes |
|
3.7* |
Non-sterile compounding processes |
|
4.0 |
Medication Safety |
12.50% |
4.1 |
Error prevention strategies for data entry (e.g., prescription or medication order to correct patient) |
|
4.2 |
Patient package insert and medication guide requirements (e.g., special directions and precautions) |
|
4.3 |
Identify issues that require pharmacist intervention (e.g., DUR, ADE, OTC recommendation, therapeutic substitution, misuse, missed dose) |
|
4.4 |
Look-alike/sound-alike medications |
|
4.5 |
High-alert/risk medications |
|
4.6 |
Common safety strategies (e.g., tall man lettering, separating inventory, leading and trailing zeros, limit use of error prone abbreviations) |
|
5.0 |
Pharmacy Quality Assurance |
7.50% |
5.1 |
Quality assurance practices for medication and inventory control systems (e.g., matching National Drug Code (NDC) number, bar code, data entry) |
|
5.2 |
Infection control procedures and documentation (e.g., personal protective equipment [PPE], needle recapping) |
|
5.3 |
Risk management guidelines and regulations (e.g., error prevention strategies) |
|
5.4 |
Communication channels necessary to ensure appropriate follow-up and problem resolution (e.g., product recalls, shortages) |
|
5.5 |
Productivity, efficiency, and customer satisfaction measures |
|
6.0 |
Medication Order Entry and Fill Process |
17.50% |
6.1* |
Order entry process |
|
6.2* |
Intake, interpretation, and data entry |
|
6.3* |
Calculate doses required |
|
6.4 |
Fill process (e.g., select appropriate product, apply special handling requirements, measure, and prepare product for final check) |
|
6.5 |
Labeling requirements (e.g., auxiliary and warning labels, expiration date, patient specific information) |
|
6.6* |
Packaging requirements (e.g., type of bags, syringes, glass, pvc, child resistant, light resistant) |
|
6.7 |
Dispensing process (e.g., validation, documentation and distribution) |
|
7.0 |
Pharmacy Inventory Management |
8.75% |
7.1 |
Function and application of NDC, lot numbers and expiration dates |
|
7.2 |
Formulary or approved/preferred product list |
|
7.3* |
Ordering and receiving processes (e.g., maintain par levels, rotate stock) |
|
7.4 |
Storage requirements (e.g., refrigeration, freezer, warmer) |
|
7.5 |
Removal (e.g., recalls, returns, outdates, reverse distribution) |
|
8.0 |
Pharmacy Billing and Reimbursement |
8.75% |
8.1 |
Reimbursement policies and plans (e.g., HMOs, PPO, CMS, private plans) |
|
8.2* |
Third party resolution (e.g., prior authorization, rejected claims, plan limitations) |
|
8.3 |
Third-party reimbursement systems (e.g., PBM, medication assistance programs, coupons, and self-pay) |
|
8.4 |
Healthcare reimbursement systems (e.g., home health, long-term care, home infusion) |
|
8.5 |
Coordination of benefits |
|
9.0 |
Pharmacy Information System Usage and Application |
10.00% |
9.1 |
Pharmacy-related computer applications for documenting the dispensing of prescriptions or medication orders (e.g., maintaining the electronic medical record, patient adherence, risk factors, alcohol drug use, drug allergies, side effects) |
|
9.2 |
|
Knowledge Domains and Areas | % of PTCE Exam Content |
1.0 Pharmacology for Technicians | 13.75% |
1.1 Generic and brand names of pharmaceuticals | |
1.2 Therapeutic equivalence | |
1.3 Drug interactions (e.g., drug-disease, drug-drug, drug-dietary supplement, drug-OTC, drug-laboratory, drug-nutrient) | |
1.4* Strengths/dose, dosage forms, physical appearance, routes of administration, and duration of drug therapy | |
1.5 Common and severe side or adverse effects, allergies, and therapeutic contraindications associated with medications | |
1.6 Dosage and indication of legend, OTC medications, herbal and dietary supplements |
2.0 Pharmacy Law and Regulations | 12.50% |
2.1 Storage, handling, and disposal of hazardous substances and wastes (e.g., MSDS) | |
2.2 Hazardous substances exposure, prevention and trea®ent (e.g., eyewash, spill kit, MSDS) | |
2.3 Controlled substance transfer regulations (DEA) | |
2.4 Controlled substance documentation requirements for receiving, ordering, returning, loss/theft, destruction (DEA) | |
2.5 Formula to verify the validity of a prescriber’s DEA number (DEA) | |
2.6 Record keeping, documentation, and record retention (e.g., length of time prescriptions are maintained on file) | |
2.7 Restricted drug programs and related prescription-processing requirements (e.g., thalidomide, isotretinoin, clozapine | |
2.8 Professional standards related to data integrity, security, and confidentiality (e.g., HIPAA, backing up and archiving) | |
2.9 Requirement for consultation (e.g., OBRA'90) | |
2.10 FDA’s recall classification | |
2.11 Infection control standards (e.g., laminar air flow, clean room, hand washing, cleaning counting trays, countertop, and equipment) (OSHA, USP 795 and 797) | |
2.12 Record keeping for repackaged and recalled products and supplies (TJC, BOP) | |
2.13 Professional standards regarding the roles and responsibilities of pharmacists, pharmacy technicians, and other pharmacy employees (TJC, BOP) | |
2,14 Reconciliation between state and federal laws and regulations | |
2.15 Facility, equipment, and supply requirements (e.g., space requirements, prescription file storage, cleanliness, reference materials) (TJC, USP, BOP) |
3.0 Sterile and Non-Sterile Compounding | 8.75% |
3.1 Infection control (e.g., hand washing, PPE) | |
3.2 Handling and disposal requirements (e.g., receptacles, waste streams) | |
3.3* Documentation (e.g., batch preparation, compounding record) | |
3.4* Determine product stability (e.g., beyond use dating, signs of incompatibility) | |
3.5 Selection and use of equipment and supplies | |
3.6* Sterile compounding processes | |
3.7* Non-sterile compounding processes |
4.0 Medication Safety | 8.75% |
4.1 Error prevention strategies for data entry (e.g., prescription or medication order to correct patient) | |
4.2 Patient package insert and medication guide requirements (e.g., special directions and precautions) | |
4.3 Identify issues that require pharmacist intervention (e.g., DUR, ADE, OTC recommendation, therapeutic substitution, misuse, missed dose) | |
4.4 Look-alike/sound-alike medications | |
4.5 High-alert/risk medications | |
4.6 Common safety strategies (e.g., tall man lettering, separating inventory, leading and trailing zeros, limit use of error prone abbreviations) |
5.0 Pharmacy Quality Assurance | 7.50% |
5.1 Quality assurance practices for medication and inventory control systems (e.g., matching National Drug Code (NDC) number, bar code, data entry) | |
5.2 Infection control procedures and documentation (e.g., personal protective equipment [PPE], needle recapping) | |
5.3 Risk management guidelines and regulations (e.g., error prevention strategies) | |
5.4 Communication channels necessary to ensure appropriate follow-up and problem resolution (e.g., product recalls, shortages) | |
5.5 Productivity, efficiency, and customer satisfaction measures |
6.0 Medication Order Entry and Fill Process | 17.50% |
6.1* Order entry process | |
6.2* Intake, interpretation, and data entry | |
6.3* Calculate doses required | |
6.4 Fill process (e.g., select appropriate product, apply special handling requirements, measure, and prepare product for final check) | |
6.5 Labeling requirements (e.g., auxiliary and warning labels, expiration date, patient specific information) | |
6.6* Packaging requirements (e.g., type of bags, syringes, glass, pvc, child resistant, light resistant) | |
6.7 Dispensing process (e.g., validation, documentation and distribution) |
7.0 Pharmacy Inventory Management | 8.75% |
7.1 Function and application of NDC, lot numbers and expiration dates | |
7.2 Formulary or approved/preferred product list | |
7.3* Ordering and receiving processes (e.g., maintain par levels, rotate stock) | |
7.4 Storage requirements (e.g., refrigeration, freezer, warmer) | |
7.5 Removal (e.g., recalls, returns, outdates, reverse distribution) |
8.0 Pharmacy Billing and Reimbursement | 8.75% |
8.1 Reimbursement policies and plans (e.g., HMOs, PPO, CMS, private plans) | |
8.2* Third party resolution (e.g., prior authorization, rejected claims, plan limitations) | |
8.3 Third-party reimbursement systems (e.g., PBM, medication assistance programs, coupons, and self-pay) | |
8.4 Healthcare reimbursement systems (e.g., home health, long-term care, home infusion) | |
8.5 Coordination of benefits |
9.0 Pharmacy Information System Usage and Application | 10.00% |
9.1 Pharmacy-related computer applications for documenting the dispensing of prescriptions or medication orders (e.g., maintaining the electronic medical record, patient adherence, risk factors, alcohol drug use, drug allergies, side effects) | |
9.2 Databases, pharmacy computer applications, and documentation management (e.g., user access, drug database, interface, inventory report, usage reports, override reports, diversion reports) |
*denotes content including calculations.